Picture of BetterLife Pharma logo

BETR BetterLife Pharma Balance Sheet

0.000.00%
ca flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Annual balance sheet for BetterLife Pharma, fiscal year end - January 31st, CAD millions except per share, conversion factor applied.

2022
January 31st
2023
January 31st
2024
January 31st
2025
January 31st
2026
January 31st
Period Length:
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Cash
Cash and Short Term Investments0.1740.0080.0370.0080.013
Net Total Accounts Receivable
Net Total Receivables0.3250.0170.040.0120.003
Prepaid Expenses
Total Current Assets1.140.0750.3250.2250.22
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment0.0180
Net Intangible Assets
Total Assets1.160.0750.3250.2250.22
Payable / Accrued
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities4.147.156.837.546.68
Long Term Debt
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Liabilities5.0410.811.110.910
Common Stock
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity-3.88-10.7-10.8-10.7-9.78
Total Liabilities & Shareholders' Equity1.160.0750.3250.2250.22
Total Common Shares Outstanding